Inflammation

Inflammation is a coordinated defense response the body mounts when tissue is damaged, infected, or otherwise stressed. The classical signs — redness, warmth, swelling, and pain — reflect changes in local blood flow and cellular behavior that are fundamentally protective.

The process takes two broad forms. Acute inflammation is rapid and self-limiting: it clears the threat and then resolves. Chronic inflammation persists beyond the original trigger, either because that trigger is ongoing or because the resolution machinery fails; sustained low-grade inflammatory signaling is understood to contribute to wide-ranging organ-level changes over time.

The bare term specifies no tissue. Neuroinflammation (in the brain), inflammation of the heart muscle, and inflammation of the bladder lining are all inflammatory processes, but their significance, time course, and outcomes differ substantially. Context always matters.

How it works · its role

Inflammation begins when cells detect damage or foreign material through molecular sensors. Injured or infected cells release signaling molecules — cytokines such as interleukin-1β and tumor necrosis factor-α, along with prostaglandins and histamine — which cause blood vessels to dilate and become more permeable, delivering fluid and immune cells to the affected site.

Neutrophils arrive first, engulfing debris and pathogens. Macrophages follow, sustaining the response and — when the threat is cleared — releasing anti-inflammatory mediators such as interleukin-10 and resolvins that wind the process down.

When this resolution phase fails, or the underlying stimulus persists, inflammation becomes chronic. Immune cells remain activated, and the resulting signaling environment can gradually alter surrounding tissue structure and function.

Relevance to substances & effects

Several well-established substance classes act directly on inflammatory pathways. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and aspirin inhibit cyclooxygenase enzymes, blocking prostaglandin synthesis and reducing pain, fever, and local swelling. Corticosteroids act more broadly, suppressing cytokine production across multiple pathways.

The brain has its own resident immune cells — microglia — that drive neuroinflammation when activated. Chronic or heavy alcohol use is associated with sustained microglial activation, contributing to neurological changes beyond the acute effects of intoxication. Opioids interact with toll-like receptor 4 on microglia, and chronic exposure is thought to promote a low-grade neuroinflammatory state that may influence tolerance and withdrawal.

Cannabinoids engage CB2 receptors expressed on immune cells throughout the body, modulating cytokine release — one reason cannabis compounds are investigated as potential anti-inflammatory agents, though the clinical picture is more complex than receptor pharmacology alone suggests. Some early research indicates that certain serotonergic psychedelics may have anti-inflammatory properties through serotonergic or sigma-1 receptor mechanisms, but this area remains in its early stages.